The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 28, 2018
Filed:
Feb. 27, 2015
Applicant:
Nucorion Pharmaceuticals, Inc., Wilmington, DE (US);
Inventors:
Assignee:
NUCORION PHARMACEUTICALS, INC., Wilmington, DE (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); C07H 19/06 (2006.01); C07H 19/10 (2006.01); C07H 19/11 (2006.01); A61K 45/06 (2006.01); A61K 31/7068 (2006.01); A61K 31/7064 (2006.01); A61K 31/706 (2006.01);
U.S. Cl.
CPC ...
C07H 19/06 (2013.01); A61K 45/06 (2013.01); C07H 19/10 (2013.01); C07H 19/11 (2013.01); A61K 31/706 (2013.01); A61K 31/7064 (2013.01); A61K 31/7068 (2013.01);
Abstract
Gemcitabine analogs, including monophosphorylated analogs, are described herein and are suitable for use in pharmaceutical compositions, kits and treatment methods. The treatment methods include treatment of viral infections, including, but not limited to, treatment of Hepatitis C Virus, and uncontrolled cellular proliferation, including cancer, such as, but not limited to, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer, liver cancer, esophageal cancer and lymphoma.